
Dandelion Science is a US-Swiss company pioneering Generative Neuromodulation™. Their platform aims to program network dynamics in the brain to treat brain disorders, moving beyond traditional neurochemical approaches with broad side effects. They are developing precision sensory stimulation therapies using generative AI to synthesize treatments on demand. Their work is supported by partnerships with institutions like the Wyss Center Geneva and the Swiss Federal Institute of Technology (EPFL), and funding from the NIH and the Swiss Innovation Agency. Dandelion Science holds significant intellectual property and has received recognition such as the Breakthrough Technology Award from The American Macular Degeneration Foundation for their potential to transform vision treatment paradigms.

Dandelion Science is a US-Swiss company pioneering Generative Neuromodulation™. Their platform aims to program network dynamics in the brain to treat brain disorders, moving beyond traditional neurochemical approaches with broad side effects. They are developing precision sensory stimulation therapies using generative AI to synthesize treatments on demand. Their work is supported by partnerships with institutions like the Wyss Center Geneva and the Swiss Federal Institute of Technology (EPFL), and funding from the NIH and the Swiss Innovation Agency. Dandelion Science holds significant intellectual property and has received recognition such as the Breakthrough Technology Award from The American Macular Degeneration Foundation for their potential to transform vision treatment paradigms.